See more with C-MORE: Addressing the need of robust cardiomyocyte morphological assessment

Rhys Wardman1,2, Joerg Heineke1,2

  • 1Department of Cardiovascular Physiology, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Cell Reports. Medicine
|November 29, 2021
PubMed

Insights

Researchers developed C-MORE, a new high-content assay for detailed cardiomyocyte morphology assessment. This method offers a more comprehensive analysis than current limited parameters, benefiting cardiovascular medicine research and clinical applications.

Area of Science:

  • Cardiovascular Medicine
  • Cell Biology
  • High-Content Imaging

Background:

  • Current methods for assessing cardiomyocyte morphology are limited in scope.
  • Comprehensive analysis is crucial for both research and clinical applications in cardiovascular medicine.

Purpose of the Study:

  • To introduce C-MORE, a novel high-content single-cell morphology assay.
  • To provide a more robust and comprehensive method for cardiomyocyte morphology assessment.

Main Methods:

  • Development of the C-MORE assay.
  • Application of high-content imaging for single-cell analysis.
  • Detailed morphological parameter quantification.

Main Results:

  • C-MORE enables a more comprehensive assessment of cardiomyocyte morphology.
  • The assay addresses limitations of existing methods.
  • Provides detailed morphological data for cardiovascular research.

Conclusions:

  • C-MORE represents a significant advancement in cardiomyocyte morphology analysis.
  • The assay has potential applications in cardiovascular medicine research and diagnostics.